Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)75-80
JournalAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Volume1
Issue number1
DOIs
Publication statusPublished - 2015

Cite this

@article{898717052383423298dbb5c0b75c8382,
title = "Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?",
author = "{Del Campo Milan}, M. and L. Zuroff and C.R. Jimenez and P. Scheltens and C.E. Teunissen",
year = "2015",
doi = "10.1016/j.dadm.2014.11.008",
language = "Undefined/Unknown",
volume = "1",
pages = "75--80",
journal = "Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring",
issn = "2352-8729",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?

AU - Del Campo Milan, M.

AU - Zuroff, L.

AU - Jimenez, C.R.

AU - Scheltens, P.

AU - Teunissen, C.E.

PY - 2015

Y1 - 2015

U2 - 10.1016/j.dadm.2014.11.008

DO - 10.1016/j.dadm.2014.11.008

M3 - Article

VL - 1

SP - 75

EP - 80

JO - Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

JF - Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

SN - 2352-8729

IS - 1

ER -